| Product Code: ETC7637659 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Plasma Protease C1-inhibitor Treatment Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Plasma Protease C1-inhibitor Treatment Market - Industry Life Cycle |
3.4 Ireland Plasma Protease C1-inhibitor Treatment Market - Porter's Five Forces |
3.5 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume Share, By Dosage Type, 2021 & 2031F |
3.7 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Plasma Protease C1-inhibitor Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about plasma protease C1-inhibitor treatments in Ireland |
4.2.2 Growing prevalence of hereditary angioedema (HAE) in the region |
4.2.3 Advancements in research and development leading to improved treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with plasma protease C1-inhibitor treatments |
4.3.2 Limited accessibility to specialized healthcare facilities offering these treatments |
4.3.3 Regulatory challenges and approval processes affecting market entry |
5 Ireland Plasma Protease C1-inhibitor Treatment Market Trends |
6 Ireland Plasma Protease C1-inhibitor Treatment Market, By Types |
6.1 Ireland Plasma Protease C1-inhibitor Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By C1-inhibitors, 2021- 2031F |
6.1.4 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By C1-esterase Inhibitor, 2021- 2031F |
6.1.5 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Kallikrein Inhibitor (Kalbitor), 2021- 2031F |
6.1.6 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist (Firazyr), 2021- 2031F |
6.2 Ireland Plasma Protease C1-inhibitor Treatment Market, By Dosage Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Liquid/Injectable, 2021- 2031F |
6.2.3 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Lyophilized, 2021- 2031F |
6.3 Ireland Plasma Protease C1-inhibitor Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Ireland Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Independent Pharmacies and Outlets, 2021- 2031F |
7 Ireland Plasma Protease C1-inhibitor Treatment Market Import-Export Trade Statistics |
7.1 Ireland Plasma Protease C1-inhibitor Treatment Market Export to Major Countries |
7.2 Ireland Plasma Protease C1-inhibitor Treatment Market Imports from Major Countries |
8 Ireland Plasma Protease C1-inhibitor Treatment Market Key Performance Indicators |
8.1 Number of patients receiving plasma protease C1-inhibitor treatment in Ireland |
8.2 Average waiting time for patients to access treatment |
8.3 Research and development investment in new treatment options |
9 Ireland Plasma Protease C1-inhibitor Treatment Market - Opportunity Assessment |
9.1 Ireland Plasma Protease C1-inhibitor Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Plasma Protease C1-inhibitor Treatment Market Opportunity Assessment, By Dosage Type, 2021 & 2031F |
9.3 Ireland Plasma Protease C1-inhibitor Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Plasma Protease C1-inhibitor Treatment Market - Competitive Landscape |
10.1 Ireland Plasma Protease C1-inhibitor Treatment Market Revenue Share, By Companies, 2024 |
10.2 Ireland Plasma Protease C1-inhibitor Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here